Groundbreaking Study Identifies Molecular Feedback Loop Driving Aggressive Progression of Hepatocellular Carcinoma Under Hypoxic Conditions

Scientists reveal how the UBE2V1-HIF-1α feedback loop accelerates HCC progression, offering a new therapeutic target for aggressive liver cancer treatment.

By: AXL Media

Published: Mar 13, 2026, 4:57 AM EDT

Source: Information for this report was sourced from [Research]

Groundbreaking Study Identifies Molecular Feedback Loop Driving Aggressive Progression of Hepatocellular Carcinoma Under Hypoxic Conditions - article image
Groundbreaking Study Identifies Molecular Feedback Loop Driving Aggressive Progression of Hepatocellular Carcinoma Under Hypoxic Conditions - article image

The Impact of Hypoxia on Liver Cancer Aggression

Hepatocellular carcinoma, or HCC, accounts for nearly 90% of primary liver cancers and remains one of the most aggressive malignancies worldwide. A defining hallmark of the HCC tumor microenvironment is hypoxia, a state of low oxygen that drives tumor progression and leads to poor patient outcomes. The central regulator of this response is the hypoxia-inducible factor HIF-1α, which normally undergoes rapid degradation but becomes aberrantly stable in advanced cancer stages.

Identification of UBE2V1 as a Hypoxia-Responsive Gene

A collaborative research effort between Zhejiang Provincial People’s Hospital and Xi’an Jiaotong University has identified UBE2V1 as a novel gene activated specifically by low-oxygen conditions. The study found that HIF-1α directly binds to a specific hypoxia-response element within the UBE2V1 promoter region. This transcriptional activation leads to the frequent overexpression of UBE2V1 in HCC tissues, a phenomenon that correlates strongly with advanced tumor stages and decreased survival rates.

The Competitive Mechanism of VHL Protein Degradation

The researchers discovered that UBE2V1 promotes tumor growth by interfering with the body's natural waste-disposal system for proteins. Specifically, upregulated UBE2V1 competes with HIF-1α for binding to the VHL protein, which is responsible for tagging HIF-1α for destruction. By forming a complex with another enzyme, UBE2S, UBE2V1 catalyzes the degradation of the VHL protein itself. This process effectively removes the "brakes" that would otherwise keep cancer-promoting factors in check.

Categories

Topics

Related Coverage